164 related articles for article (PubMed ID: 8909222)
21. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
22. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
[TBL] [Abstract][Full Text] [Related]
24. Fluorescein angiographic findings in a case of cancer-associated retinopathy.
Masaoka N; Emoto Y; Sasaoka A; Fukushima A; Ueno H; Ohguro H
Retina; 1999; 19(5):462-4. PubMed ID: 10546949
[No Abstract] [Full Text] [Related]
25. Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
Kashiwabara K; Nakamura H; Kishi K; Yagyu H; Sarashina G; Kobayashi K; Matsuoka T
Intern Med; 1999 Jul; 38(7):597-601. PubMed ID: 10435368
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic cone dysfunction: an unusual visual remote effect of cancer.
Jacobson DM; Thirkill CE
Arch Ophthalmol; 1995 Dec; 113(12):1580-2. PubMed ID: 7487640
[No Abstract] [Full Text] [Related]
27. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
28. Invasive thymoma with paraneoplastic retinopathy.
Yamada G; Ohguro H; Aketa K; Itoh T; Shijubo N; Takahashi H; Fujiwara O; Satoh M; Ohtsuka K; Abe S
Hum Pathol; 2003 Jul; 34(7):717-9. PubMed ID: 12874770
[TBL] [Abstract][Full Text] [Related]
29. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
30. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.
Maeda A; Maeda T; Ohguro H; Palczewski K; Sato N
Eur J Immunol; 2002 Aug; 32(8):2300-7. PubMed ID: 12209643
[TBL] [Abstract][Full Text] [Related]
31. Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes.
Adamus G; Amundson D
J Neurosci Res; 1996 Sep; 45(6):863-72. PubMed ID: 8892098
[TBL] [Abstract][Full Text] [Related]
32. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
33. Experimental, cancer-induced retinopathy.
Thirkill CE
Ocul Immunol Inflamm; 1997 Mar; 5(1):55-65. PubMed ID: 9145694
[No Abstract] [Full Text] [Related]
34. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
[TBL] [Abstract][Full Text] [Related]
35. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
36. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
37. Management and monitoring of cancer-associated retinopathy.
Keltner JL; Thirkill CE; Tyler NK; Roth AM
Arch Ophthalmol; 1992 Jan; 110(1):48-53. PubMed ID: 1310001
[TBL] [Abstract][Full Text] [Related]
38. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
Adamus G; Machnicki M; Seigel GM
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
[TBL] [Abstract][Full Text] [Related]
39. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
